| |
| |
|
| Insider
Information: |
Utter Christine Marie |
| Relationship: |
|
| City: |
South Plainfield |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
52,428 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,762,629 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
52,428 |
|
|
| Total
Value |
$1,762,629 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
9
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
8
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -234.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
PTC Therapeutics, Inc. |
PTCT |
|
2024-02-15 |
52,428 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PTCT |
PTC Therapeutics, Inc. |
SVP, CHIEF ACCOUNTING OFFICER |
• – – |
2024-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
16,900 |
52,428 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, CHIEF ACCOUNTING OFFICER |
• – – |
2024-01-30 |
4 |
S |
$27.25 |
$8,666 |
D/D |
(318) |
35,528 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, FINANCE & CAO |
• – – |
2024-01-09 |
4 |
S |
$29.01 |
$47,961 |
D/D |
(1,653) |
35,846 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, FINANCE & CAO |
• – – |
2024-01-08 |
4 |
S |
$28.64 |
$34,025 |
D/D |
(1,188) |
37,499 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, FINANCE & CAO |
• – – |
2023-04-21 |
4 |
AS |
$55.05 |
$258,326 |
D/D |
(4,692) |
38,059 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, FINANCE & CAO |
• – – |
2023-04-21 |
4 |
OE |
$33.02 |
$154,930 |
D/D |
4,692 |
38,430 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, FINANCE & CAO |
• – – |
2023-03-27 |
4 |
OE |
$33.02 |
$880,247 |
D/D |
26,658 |
47,788 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, FINANCE & CAO |
• – – |
2023-03-27 |
4 |
AS |
$44.71 |
$1,202,106 |
D/D |
(26,658) |
38,059 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, FINANCE & CAO |
• – – |
2023-01-31 |
4 |
S |
$45.63 |
$14,829 |
D/D |
(325) |
38,059 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, FINANCE & CAO |
• – – |
2023-01-11 |
4 |
S |
$44.36 |
$18,498 |
D/D |
(417) |
38,384 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, FINANCE & CAO |
• – – |
2023-01-10 |
4 |
S |
$42.93 |
$20,994 |
D/D |
(489) |
38,801 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, FINANCE & CAO |
• – – |
2023-01-09 |
4 |
S |
$41.66 |
$29,409 |
D/D |
(706) |
39,290 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, FINANCE & CAO |
• – – |
2023-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
39,996 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, Finance & CAO |
• – – |
2022-02-02 |
4 |
AS |
$40.38 |
$28,549 |
D/D |
(707) |
25,405 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, Finance & CAO |
• – – |
2022-02-01 |
4 |
AS |
$40.00 |
$12,521 |
D/D |
(313) |
26,112 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, Finance & CAO |
• – – |
2022-01-18 |
4 |
AS |
$43.50 |
$502,118 |
D/D |
(11,428) |
26,425 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, Finance & CAO |
• – – |
2022-01-18 |
4 |
OE |
$18.01 |
$180,100 |
D/D |
10,000 |
36,425 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, Finance & CAO |
• – – |
2022-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
11,600 |
27,853 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, Finance & CAO |
• – – |
2022-01-07 |
4 |
S |
$38.53 |
$28,778 |
D/D |
(747) |
16,253 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, Finance & CAO |
• – – |
2021-02-08 |
4 |
OE |
$33.02 |
$87,734 |
D/D |
2,657 |
19,166 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, Finance & CAO |
• – – |
2021-02-08 |
4 |
AS |
$66.00 |
$175,362 |
D/D |
(2,657) |
16,509 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, Finance & CAO |
• – – |
2021-02-02 |
4 |
AS |
$57.64 |
$37,581 |
D/D |
(652) |
16,509 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, Finance & CAO |
• – – |
2021-02-01 |
4 |
AS |
$56.96 |
$20,960 |
D/D |
(368) |
17,161 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, Finance & CAO |
• – – |
2021-01-13 |
4 |
AS |
$66.57 |
$262,752 |
D/D |
(3,947) |
17,529 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
SVP, Finance & CAO |
• – – |
2021-01-13 |
4 |
OE |
$11.23 |
$53,874 |
D/D |
3,288 |
20,029 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
